Near-IR Laser Imaging Determines Malignancy Risk Level in Pancreatic Tissues
Researchers headed by Nicusor Iftimia of Physical Sciences, Inc. have found that optical coherence tomography (OCT) is well suited to differentiate between pancreatic cysts with low and high malignancy risk.
OCT uses an optical imaging system of high resolution and reflects near-infrared laser beam away from biological tissues. This is helpful in diagnostic applications.
Researchers used the OCT scanning method to find out the unique features of the malignant cysts and thus developed certain visual standards to distinguish between high- and low- malignancy risk pancreatic cysts. The team also examined samples of pancreatic tissues that were surgically removed from patients with pancreatic cysts. The visual criteria was verified by comparing the results of OCT with that of microscopic examination of the thin sections of the tissue. The outcome of this experiment was published in the August issue of Biomedical Optics Express, a journal of the Optical Society. The study showed that OCT scan results were found to be very close to that of microscopic examination of samples and OCT is a reliable technique for differentiating high- and low malignancy risk pancreatic cysts.
The research team will concentrate on enhancing the resolution of imaging to differentiate between autoimmune pancreatitis and solid lesions, and test this phenomenon in vivo. The FDA had recently approved OCT testing in humans with the help of a compact OCT probe which can be introduced in to the pancreas using a biopsy needle. This needle will be guided towards the suspected malignant tissue using the endoscopic ultrasound imaging technique.
A clinical study will be initiated within a few months. If the results of in vivo testing prove to be satisfactory, then the studies will be extended to a larger number of patients, subject to approval by the FDA and NIH funding.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Choi, Andy. (2019, February 28). Near-IR Laser Imaging Determines Malignancy Risk Level in Pancreatic Tissues. AZoOptics. Retrieved on February 03, 2026 from https://www.azooptics.com/News.aspx?newsID=14251.
MLA
Choi, Andy. "Near-IR Laser Imaging Determines Malignancy Risk Level in Pancreatic Tissues". AZoOptics. 03 February 2026. <https://www.azooptics.com/News.aspx?newsID=14251>.
Chicago
Choi, Andy. "Near-IR Laser Imaging Determines Malignancy Risk Level in Pancreatic Tissues". AZoOptics. https://www.azooptics.com/News.aspx?newsID=14251. (accessed February 03, 2026).
Harvard
Choi, Andy. 2019. Near-IR Laser Imaging Determines Malignancy Risk Level in Pancreatic Tissues. AZoOptics, viewed 03 February 2026, https://www.azooptics.com/News.aspx?newsID=14251.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.